Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative ECF Chemotherapy vs Surgery Alone in Operable Gastric Cancer
NCT00002615Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Jun 1994
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of epirubicin, cisplatin and fluorouracil in gastric cancer (GC) (2 arms), sponsored by Medical Research Council. Primary endpoints: Overall Survival and Quality of Life. Started Jun 1994; status: completed.
02
Drugs
epirubicincisplatinfluorouracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00002615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002615.